What is the CVSS score of CVE-2019-15933?

CVE-2019-15933 has a CVSS 3.1 base score of 9.8 (Critical). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 2.0%.

Is there a public PoC exploit available for CVE-2019-15933?

Yes, a public proof-of-concept exploit is available for CVE-2019-15933. Prioritise patching immediately. EPSS: 2.0%.

Solismed CVE-2019-15933

CRITICAL

SQL Injection (CWE-89)

2019-12-12 cve@mitre.org

SQLi Solismed

9.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

9.8 CRITICAL

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Dec 12, 2019 - 14:15 nvd

CRITICAL 9.8

DescriptionNVD

Intesync Solismed 3.3sp has SQL Injection.

AnalysisAI

Intesync Solismed 3.3sp has SQL Injection. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as SQL Injection (CWE-89), which allows attackers to execute arbitrary SQL commands against the database. Affected products include: Intesync Solismed.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Use parameterized queries/prepared statements. Never concatenate user input into SQL. Apply least-privilege database permissions.